Hospital Universitario La Fe
Valencia, Spain
NCT Number: NCT05879536
It will be a prospective observational cohort study. The investigators will compare post-cesarean section recovery in patients receiving intravenous infusion of tramadol-ondansetron versus epidural catheter with infusion of local anesthetics.
Looking for future studies?
Notify Me18 year–50 year
Female
Observational
Valencia, Spain
The primary outcome is to assess the non-inferiority in terms of post-cesarean section recovery of the intravenous perfusion of tramadol + ondansetron compared to the perfusion of local anesthetics through an epidural catheter.
This will be a prospective observational cohort study, with a total N of 312 patients who underwent a cesarean section. 156 who maintain the epidural catheter as the main measure of analgesia for 24 h, and 156 who receive an infusion of tramadol-ondansetron from the end of the cesarean section and for the following 24 h. The following data will be collected at 24 and 48 hours: need for unscheduled pharmacological reinforcement, adverse effects, QoR (Quality of Recovery) score 15, ObsQor-10 (Obstetric Quality of Recovery) score, and Visual Analogue Pain Scale (VAS) every 4 hours for 48 hours. The incidence of chronic pain 90 days after cesarean section will be assessed using the Numerical Pain Rating Scale (NRS).
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Analgesia strategy determined by routine use according to protocols, without investigator intervention.
Analgesia strategy determined by routine use according to protocols, without investigator intervention.
Time frame: Day 1
QoR-15 score at 24 hours after cesarean section
Time frame: Day 1
Pain score evolution on the sequential Visual Analogue Scale at 24 hours, measured every 4 hours.
Time frame: Day 1
Presence or absence of the next adverse effects: Pruritus; tremors; urinary retention or need for a bladder catheter; Constipation or abdominal distension; limitation of mobility; delayed initiation of breastfeeding if desired (due to analgesia); need for blood extraction for control analysis.
Time frame: Day 1
ObsQor-10 score at 24 hours.
Time frame: Day 2
QoR-15 score at 48 hours after cesarean section
Time frame: Day 2
Presence or absence of the next adverse effects: Pruritus; tremors; urinary retention or need for a bladder catheter; Constipation or abdominal distension; limitation of mobility; delayed initiation of breastfeeding if desired (due to analgesia); need for blood extraction for control analysis.
Time frame: Day 2
Pain score evolution on the sequential Visual Analogue Scale at 48 hours, measured every 4 hours.
Time frame: Day 90
Chronic pain measured by numerical rating scale at 90 days of TRON versus AL-EPI.
Hospital Universitario La Fe
Other
The Effect of Intravenous Infusion of Tramadol-ondansetron on Recovery After Caesarean Section. A Prospective, Observational and Non-inferiority Study Against Epidural Analgesia.
Acronym: TRON
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05965544
Anesthesia, Local, Femoral Fractures
Küçükçekmece, İ̇stanbul, Turkey (Türkiye)
View Trial DetailsNCT06108895
Cesarean Section, Neurologic Manifestations
Tanta, Gharbiah, Egypt
View Trial DetailsNCT04988893
Body Weight, Neurologic Manifestations
London, Ontario, Canada
View Trial DetailsNCT07202416
Cesarean Section, Neurologic Manifestations
Cesena, Forlì, Italy
View Trial Details